ZIKV ZIKV-E recombinant protein (C-His)

Cat.#: 514916

Size:

Special Price 621.5 USD

Availability: In Stock
- +

Add to cart to get an online quotation

Product Information

  • Product Name
    ZIKV ZIKV-E recombinant protein (C-His)
  • Documents
  • Description
    Envelope of Zika virus is resposible for receptor binding and membrane. Analysis of the envelope protein of Zika, from Brazilian Zika SPH2015 (KU321639), indicates predicted B and T cell epitopes in peptides that are consistent to those reported for dengue, YFYF and Japanese encephalitis.The envelope Domain II B cell epitope, to which much dengue non-neutralizing cross reaction is attributed, is also conserved also in Zika virus, consistent with prior field observations of cross reactivity with dengue and YF. Domain III of the Zika envelope protein, likely the main specific neutralizing domain, is distinct from recent Brazilian dengue isolates and a recent Peruvian YF isolate (GQ379163), 76% of possible major histocompatibility complex class (MHC) I and MHC II binding peptides and potential B cell linear epitopes are unique to Zika virus.
  • Uniprot ID
    ALU33341.1
  • Source/Expression Host
    Baculovirus-Insect Cells
  • Expression Plasmid/cDNA
    A DNA sequence encoding the Zika virus (strain Zika SPH2015) E / Envelope (domain III) (ALU33341.1) (Val593-Lys699) was expressed with a polyhistidine tag at the C-terminus.
  • Protein Species
    ZIKV
  • Molecular weight
    The recombinant Zika virus (strain Zika SPH2015) E / Envelope (domain III) consists of 118 amino acids and predicts a molecular mass of 13 kDa.
  • Purity
    > 95 % as determined by SDS-PAGE.
  • Validations

    ZIKV Envelope / Zika-E Protein 14957

    ZIKV Envelope / Zika-E Protein 14957

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"